HK Doctors Prefer Chinese Covid Vaccine: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1571820_1_20210122181304.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.htm', 'DCS.dcsqry', '' ); } } }); }); });

2021-01-22 HKT 16:18

Share this story

facebook

  • HK doctors prefer Chinese Covid vaccine: survey

A pro-government healthcare workers' group and four unions in the medical sector say a survey they've carried out suggests Hong Kong doctors, nurses and dentists prefer China's Sinovac coronavirus jabs to those developed overseas.

Medical Conscience said on Friday that they polled 930 healthcare workers, including 444 doctors and 318 dentists, regarding the three vaccines the Hong Kong government has procured so far.

Sixty-one percent said their preferred vaccine would be the one made by Sinovac, while 22 percent opted for the one made by Germany's BioNTech and 11 percent the jab from Anglo-Swedish company AstraZeneca.

Five percent of the respondents said they would refuse to take Covid-19 vaccines altogether.

Medical Conscience said the survey was carried out between January 7 and January 14.

Researchers in Brazil only made public the findings of their late-stage trials of the Sinovac jabs on January 13, saying it has an efficacy rate of 50.4 percent - lower than those of the other two.

But Dr David Lam from Medical Conscience said many in the medical sector already knew that Sinovac was their favourite, because it is made in a more conventional way, using inactivated virus particles.

"Maybe doctors and nurses are kind of more conservative people so they choose something they know well. That’s probably the reason why more people chose the inactivated virus technology," Lam said at a press conference.

"I wouldn’t really put too much emphasis on the branding of the vaccines, but rather the technology behind them."

Lam also said he has no problem with the government’s plan to prioritise care home residents and staff over healthcare workers when the inoculation programme is launched.

He said while he believes doctors and nurses should be among the first groups of people to get the jabs, they don't need to be right at the front of the queue because they are well-trained and can protect themselves using their professional knowledge.

RECENT NEWS

Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity

Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more

BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom

BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more

Webinar: When Account Takeover Moves Past Onboarding

Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more

JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson

JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more

Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term

The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more

Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal

Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more